Case Report
Published on 03 Mar 2026
Successful use of obinutuzumab in focal segmental glomerulosclerosis with inadequate response to rituximab: a case report
in Glomerular disease
- 124 views
Case Report
Published on 03 Mar 2026
in Glomerular disease
Original Research
Published on 03 Mar 2026
in Sustainable Infrastructure
Original Research
Published on 03 Mar 2026
in Infectious Agents and Disease
Original Research
Published on 03 Mar 2026
in Engine and Automotive Engineering
Original Research
Published on 03 Mar 2026
in Environmental Health and Exposome
Original Research
Published on 03 Mar 2026
in Occupational Health and Safety
Original Research
Published on 03 Mar 2026
in Infectious Agents and Disease
Brief Research Report
Published on 03 Mar 2026
in Health Informatics
Correction
Published on 03 Mar 2026
in Immunological Memory
Editorial
Published on 03 Mar 2026
in Inflammation
Original Research
Published on 03 Mar 2026
in Occupational Health and Safety
Systematic Review
Published on 03 Mar 2026
in Cancer Immunity and Immunotherapy
Perspective
Published on 03 Mar 2026
in Health Economics
Case Report
Published on 03 Mar 2026
in Pediatric Oncology
Correction
Published on 03 Mar 2026
in Environmental Policy and Governance
Editorial
Published on 03 Mar 2026
in Rheumatology